Times of IndiaHigh body mass index is not always an indicator for heart disease: StudyTimes of IndiaMUMBAI: Women who have a good metabolism need not worry about heart diseases – even if they are overweight and have a high body mass index (BMI). Dr Sor…
Amgen, Cytokinetics Report Mixed Results for Heart Failure Drug – TheStreet.com
Amgen, Cytokinetics Report Mixed Results for Heart Failure DrugTheStreet.comBut heart failure patients treated with the highest dose of the drug, known as omecamtiv mecarbil, were able to breathe easier and showed sufficient, additional clinical improv…
Transplant games are pure gold for Sheeba – Northamptonshire Telegraph
|
Transplant games are pure gold for Sheeba
Northamptonshire Telegraph “My sister in India had the same condition and was on dialysis for seven years. “Sadly she died before a donor could be found. “I was given the gift of … She said: “I want to promote organ donation and the work of the Donor Family Network. “They have … |
Protect yourself from injuries – Indianapolis Recorder
Protect yourself from injuriesIndianapolis RecorderA second injury can cause short-term memory problems, long-term memory problems, learning difficulty, depression, mood disorders, brain swelling and, in the worst case, brain death. What are some of th…
Surveyed U.S. Neurologists Are More Likely Than Payers to Consider Biogen … – The Providence Journal
|
Surveyed U.S. Neurologists Are More Likely Than Payers to Consider Biogen …
The Providence Journal The report also finds that novel late-stage emerging disease-modifying therapies (DMTs) for the treatment of MS–Genzyme/Bayer HealthCare’s Lemtrada, Biogen Idec/AbbVie’s daclizumab and Roche/Genentech’s ocrelizumab–will generally be reserved for … |
UPDATED: PhII flop clouds future of Amgen, Cytokinetics heart failure drug – FierceBiotech
UPDATED: PhII flop clouds future of Amgen, Cytokinetics heart failure drugFierceBiotechCytokinetics shares ($CYTK) took a dive in early trading today after its partner Amgen ($AMGN) reported that an IV formulation of their heart failure drug omecamtiv …
Risk factors identified at diagnosis help predict outcomes for children with … – National Institutes of Health (press release)
National Institutes of Health (press release) |
Risk factors identified at diagnosis help predict outcomes for children with …
National Institutes of Health (press release) A long-term study of children with a complex heart condition called hypertrophic cardiomyopathy (HCM) found that the risk of death or need for immediate listing for heart transplantation was greatest for those who developed this disease as infants with … Heart muscle disease research reveals children at greatest riskThe Information Daily A Mother’s Loss Inspires Research Study that Identifies Risk Factors of Death …PR Newswire (press release) |
Governor for action on varsities' bifurcation, legislation – Economic Times
|
Governor for action on varsities’ bifurcation, legislation
Economic Times Shetty thanked the Governor for his support to the Voluntary Organ Donation Movement and screening of Thalessemia students started by the government. Chief Secretary Jayant Kumar Banthia called upon the universities to implement the sports and youth … |
Risk factors help predict outcomes for children with rare heart condition – Medical Xpress
Risk factors help predict outcomes for children with rare heart conditionMedical XpressA long-term study of children with a complex heart condition called hypertrophic cardiomyopathy (HCM) found that the risk of death or need for immediate listing for …
Surveyed U.S. Neurologists Are More Likely Than Payers to Consider Biogen … – PR Newswire (press release)
|
Surveyed U.S. Neurologists Are More Likely Than Payers to Consider Biogen …
PR Newswire (press release) The report also finds that novel late-stage emerging disease-modifying therapies (DMTs) for the treatment of MS—Genzyme/Bayer HealthCare’s Lemtrada, Biogen Idec/AbbVie’s daclizumab and Roche/Genentech’s ocrelizumab—will generally be reserved for … |